.avif)
.avif)
Travere Therapeutics Email Format
Biotechnology
・
201-500 employees
・
San Diego, CA, USA
Travere Therapeutics is a biopharmaceutical company focused on identifying, developing, and delivering life-changing therapies for people living with rare diseases.
Search our verified sources for decision-makers, emails, and titles.
Start searching
VERIFIED BY CLAY
first.last@travere.com
Company Overview
Industry
Biotechnology
Founded
2020
Headquarters
San Diego, CA, USA
Revenue
$250M-$500M
FUNDING Stage
Public
Website
Key Executives
Eric Dube, Ph.D. (President & Chief Executive Officer), Chris Cline, CFA (Chief Financial Officer), Peter Heerma (Chief Commercial Officer)
Tech Stack
Key Executives
4.9/5 on G2
40K+ GTM professionals
SOC 2 Type II certified
Frequently Asked Questions
What is the email format of Travere Therapeutics?
Travere Therapeutics uses the first.last format, so Jane Smith would be jane.smith@travere.com.
What approved products does Travere Therapeutics currently market?
Travere Therapeutics markets FILSPARI (sparsentan) for IgA Nephropathy and Focal Segmental Glomerulosclerosis, and Thiola EC and Thiola (tiopronin) for Cystinuria, making rare kidney and metabolic diseases the core of its commercial portfolio.
Where is Travere Therapeutics headquartered and how large is the company?
Travere Therapeutics is headquartered in San Diego, CA and has approximately 503 employees. Tools like Clay can help you find and verify the right contact at the company for outreach or prospecting purposes.
Who leads Travere Therapeutics as CEO in 2026?
Eric Dube, Ph.D. serves as President and Chief Executive Officer of Travere Therapeutics in 2026, with Chris Cline as Chief Financial Officer and Peter Heerma as Chief Commercial Officer rounding out the executive team.
What is Travere Therapeutics' pegtibatinase program targeting?
Pegtibatinase is Travere Therapeutics' investigational Phase 3 therapy for Classical Homocystinuria, a rare metabolic disease, being studied in the HARMONY pivotal trial.
Get access to more people and company data using Clay
Leverage the power of 100+ data providers for industry-leading data coverage & quality.
4.9 rating